Rapport Therapeutics, Inc. Common Stock

RAPPNASDAQ Global Market·USD·Closed

RAPPNASDAQ·USD·Closed

$40.98

−4.21%

$40.98

−$1.80 (4.21%)

52W Range

89thpctl

Volume

0.63×avg

Mkt Cap

1.96BUSD

P/E

-15.8TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

89thpctl

Volume

0.63×avg

Market Cap

1.96BUSD

P/E Ratio

-15.8TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-611.0%

ROIC-25.3%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio27.08×